Cancer Research

PhRMA Rebuts Bailar Assessment

Published in Cancer Weekly, June 9th, 1997

"Contrary to the allegations of a University of Chicago study published in the New England Journal of Medicine, new treatments are closing in on cancer," said Pharmaceutical Research and Manufacturers of America (PhRMA) President Alan F. Holmer in a statement responding to news reports of a study discounting the value of new cancer treatments.

"We're not ready to declare victory in the war on cancer yet, but this study seems to be saying that the we ought to surrender because defeat is imminent. That's just not true.

"More effective chemotherapy drugs have enabled doctors to zap cancer cells, while medicines to combat nausea and other side effects...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (1997-06-09)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry